Keyphrases
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Prostaglandin E2
100%
Drug Administration
100%
Leukotriene B4 (LTB4)
100%
Tissue Level
100%
Impacted Third Molar
100%
Flurbiprofen
100%
Placebo
33%
Postoperative Pain
33%
Microdialysis Probe
33%
Surgical Wound
33%
Inflammatory Mediators
22%
Pain Report
22%
Inflammation
11%
Randomized Double-blind Placebo-controlled Study
11%
Analgesia
11%
Healthy Individuals
11%
Acute Postoperative
11%
Microdialysis
11%
Eicosanoids
11%
Pain Patients
11%
Analgesic Efficacy
11%
Oral Administration
11%
Operative
11%
Peripheral Mechanisms
11%
Midazolam
11%
Tissue Concentration
11%
Dialysate
11%
Visual Analog Scale
11%
Placebo Treatment
11%
Pain Models
11%
Therapeutic Levels
11%
Tissue Injury
11%
Inflammatory Pain
11%
Local Production
11%
Surgical Removal
11%
Surgical Site
11%
Ex Vivo Tissues
11%
Recovery Room
11%
Mediator Release
11%
Molecular Weight Cut-off
11%
Semi-permeable
11%
Mepivacaine
11%
Mandibular Third Molar
11%
Dental Impaction
11%
Regional Block
11%
Block Anaesthesia
11%
Awake Patients
11%
Preoperative Administration
11%
Medicine and Dentistry
Third Molar
100%
Drug Administration
100%
Nonsteroid Antiinflammatory Agent
100%
Prostaglandin E2
100%
Leukotriene B4
100%
Flurbiprofen
100%
Placebo
44%
Surgical Wound
33%
Postoperative Pain
33%
Inflammatory Mediator
22%
Wound
11%
Analgesia
11%
Placebo-Controlled Study
11%
Prevalence
11%
Oral Drug Administration
11%
Visual Analog Scale
11%
Inflammatory Pain
11%
Tissue Injury
11%
Surgical Site
11%
Icosanoid
11%
Dialysis Fluid
11%
Mediator Release
11%
Analgesic Efficacy
11%
Postoperative Inflammation
11%
Mepivacaine
11%
Mandibular Third Molar
11%
Post-Anesthesia Care Unit
11%
Midazolam
11%
Pharmacology, Toxicology and Pharmaceutical Science
Non-Steroidal Anti-Inflammatory Drug
100%
Drug Administration
100%
Leukotriene B4
100%
Prostaglandin E2
100%
Flurbiprofen
100%
Microdialysis
44%
Placebo
44%
Postoperative Pain
33%
Surgical Wound
33%
Normal Human
11%
Midazolam
11%
Dialysis Fluid
11%
Postoperative Inflammation
11%
Placebo-Controlled Study
11%
Prevalence
11%
Icosanoid
11%
Analgesic Agent
11%
Wound
11%
Inflammatory Pain
11%
Tissue Injury
11%
Molecular Weight Cut-off
11%
Mepivacaine
11%
Oral Administration
11%